EXANE DERIVATIVES - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$87,246,000
-18.8%
8,6830.0%0.05%
+66.7%
Q1 2022$107,489,000
-37.3%
8,683
+15.8%
0.03%
-28.6%
Q4 2021$171,540,000
-45.9%
7,501
-47.7%
0.04%
-44.7%
Q3 2021$317,089,000
+102.6%
14,329
+9.0%
0.08%
+117.1%
Q2 2021$156,541,000
+37.9%
13,144
+50.4%
0.04%
+9.4%
Q1 2021$113,484,000
-19.0%
8,740
-13.7%
0.03%
-22.0%
Q4 2020$140,064,000
+86.5%
10,128
+98.6%
0.04%
+86.4%
Q3 2020$75,119,000
+36.0%
5,100
+50.0%
0.02%
+46.7%
Q2 2020$55,246,0003,4000.02%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders